Mutual Funds

Magazine articles on mutual funds.

Old Articles: <Older 2861-2870 Newer>

The Motley Fool June 17, 2011 Robyn Gearey	Who Would Buy These Stocks? Banks may be starting another race to the bottom before fully recovering from the last one.
The Motley Fool June 17, 2011 Amanda B. Kish	Father's Day Investments Why get Dad a tie, when you can get him a father-and-son fund?
The Motley Fool June 17, 2011 Selena Maranjian	Make Money in Natural Resources the Easy Way If you expect the natural resources industry to thrive as the global economy picks up, the iShares S&P North American Natural Resources ETF could save you a lot of trouble.
The Motley Fool June 17, 2011 Eric Dutram	Friday's ETF to Watch: iShares Short-Term U.S. Treasury Bond Fund Investors turn to Treasury bond funds as a safe haven from the turmoil in Europe.
The Motley Fool June 16, 2011	Here's What the Muhlenkamp Fund Bought and Sold Last Quarter Learn from this fund's top holdings and new trades.
The Motley Fool June 16, 2011	Here's What Meridian Growth Fund Bought and Sold Last Quarter At the helm of Meridian Growth Fund is Richard Aster, who puts more emphasis on long-term stocks and considers earnings growth to be the most important determinant of stock prices. Let's take a look at his recent activity.
Registered Rep. June 16, 2011 Jerry Gleeson	Morningstar's New Rating System Gazes Beyond the "Stars" Looking to give advisors new measures for evaluating funds, Morningstar plans to release a new "forward-looking" rating tool that uses its analysts' expertise to evaluate the funds' ability to outperform their benchmarks.
The Motley Fool June 16, 2011 Eric Dutram	Thursday's ETF to Watch: Homebuilders SPDR Housing stats for May are released today, making this an ETF to keep your eye on.
The Motley Fool June 15, 2011 Dan Caplinger	5 ETFs You Need to Get Rich These five ETFs give you nearly everything you need in order to build wealth.
The Motley Fool June 15, 2011 Selena Maranjian	Make Money in Biotech the Easy Way There's no need to guess which biotech company will perform best with the SPDR S&P Biotech ETF.
<Older 2861-2870 Newer> Return to current articles.